Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer
NCT ID: NCT01541358
Last Updated: 2017-06-14
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
2 participants
INTERVENTIONAL
2012-05-31
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy
NCT00725387
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
NCT00375830
18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma
NCT04365660
Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma
NCT03613259
Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone
NCT00392938
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diagnostic (fluorine F 18 sodium fluoride PET/CT)
Patients undergo fluorine F 18 sodium fluoride PET/CT scan.
fluorine F 18 sodium fluoride
Undergo fluorine F 18 sodium fluoride PET/CT scan
positron emission tomography/computed tomography
Undergo fluorine F 18 sodium fluoride PET/CT scan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fluorine F 18 sodium fluoride
Undergo fluorine F 18 sodium fluoride PET/CT scan
positron emission tomography/computed tomography
Undergo fluorine F 18 sodium fluoride PET/CT scan
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients must understand and voluntarily sign an informed consent form after the contents have been fully explained to them
Exclusion Criteria
* Pregnant women
* Healthy volunteers
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrew Quon
Associate Professor of Radiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew Quon
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2012-00138
Identifier Type: REGISTRY
Identifier Source: secondary_id
SU-02162012-9128
Identifier Type: OTHER
Identifier Source: secondary_id
VAR0074
Identifier Type: OTHER
Identifier Source: secondary_id
IRB-23082
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.